STAAR Surgical ICL Sales Up 67%; Company Raises Outlook for 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Intel shares fall as competitor reports record results
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- AMD forecast eases AI spending fears as data-center sales surge
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
STAAR Surgical (STAA) Tops Q2 EPS by 10c, Revenues Beat; Boosts Outlook
August 1, 2018 4:06 PM EDTSTAAR Surgical (NASDAQ: STAA) reported Q2 EPS of $0.09, $0.10 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $33.9 million versus the consensus estimate of $26.74 million.
Second Quarter 2018 Overview
Net Sales of $33.9 Million Up 55% from the Prior Year QuarterICL Sales Up 67% and Units Up 66% from the Prior Year QuarterOther Sales Up 18% from the Prior Year QuarterGross Margin at 74.4% of Sales from 70.5% of Sales in the Prior Year... More


